Topic: A Review of Xanomeline-Trospium
Speaker:  Dr. Andrew Muzyk

Session Objective:

  • Describe the function of the cholinergic pathway and its relevance to schizophrenia pathophysiology.  
  • Differentiate between muscarinic receptor subtypes and explain their distinct roles in psychosis.  
  • Evaluate the clinical evidence supporting muscarinic-targeting agents.  
  • Apply current evidence to formulate the patient-centered treatment recommendations incorporating cholinergic-pathway medications.

Virtual Information: Teams 

Session date: 
01/14/2026 - 12:00pm to 1:00pm EST
Location: 
Microsoft Teams
SC 29605
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    The University of South Carolina School of Medicine Greenville designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The University of South Carolina School of Medicine Greenville is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance
Please login or register to take this course.